Recent Medical press releases & news

[PRESSWIRE] BOSTON, Nov. 18, 2019 -- Biofourmis, a fast-growing global leader in digital therapeutics based in Boston, announced today it has been selected by Novartis, a global healthcare company, to collaborate on a commercial project for managing patients with heart failure (HF) beginning in Southeast Asia, with potential plans to expand globally. The goal of the program is to improve clinical outcomes by using Biofourmis' lead product BiovitalsHF™, which captures data from wearable biosensors and leverages the FDA-cleared Biovitals™ Analytics Engine to identify early signs of HF exacerbations to enable early interventions in patients with HF with reduced ejection fraction.

[PRESSWIRE] Parma, November - 18, 2019 -- High protein intake is believed to be healthy, but it may pave the way to irreversible kidney failure. The risk of the kidneys being harmed by a diet rich in proteins is especially high in people with a pre-existing low-grade chronic kidney disease, of which most of the affected people are unaware. “It is essential that people know there is another side to high-protein diets.”

[PRESSWIRE] Parma - November 12, 2019 - Diabetes is one of the key drivers of chronic kidney disease and the most frequent reason why patients are in need of renal replacement therapy. Conversely, outcomes for dialysis patients with diabetes are rather poor. For these reasons, the ERA-EDTA aims to raise awareness of the threat of kidney disease on World Diabetes Day on November 14. It is important to prevent diabetes wherever possible and if not, to take great care to ensure that kidney health is protected in diabetic patients. SGLT2 inhibitors have the potential to treat CKD in patients with diabetes.

 [PRESSWIRE] DENVER, Oct. 24, 2019 -- Aspen Laser Systems, LLC, an emerging leader in laser therapy, also referred to as Photobiomodulation, announced that it has been recognized with an award by Global Health & Pharma, a leading publication and information sharing platform, dedicated to the healthcare industry.

[PRESSWIRE] ITALY - 15 October, 2019 -- The 18th Congress of the International Pediatric Nephrology Association (IPNA) will take place in Venice, Italy, from 17-21 October 2019. IPNA’s vision is to achieve optimal care for all children with kidney disease all over the world through advocacy, education, and training in developed countries as well as in under-resourced regions. By means of the Congress and various educational programs, IPNA disseminates knowledge in order to improve the situation of more than 23,000 children on chronic renal replacement therapy.

 [PRESSWIRE] LONDON, July 29, 2019 -- In 2018, the urology devices market is estimated at $6.9bn and is expected to grow at a CAGR of 6.1% from 2018 to 2029. The urinary incontinence market dominated the market in 2018 and accounted for 33.8% of the urology devices market.

[PRESSWIRE] London - 09 July 2019 -- The exclusion of patients with kidney diseases from clinical trials remains an unsolved problem that hinders optimal care of these patients. Over 850 million people suffer from kidney diseases worldwide, a number which signifies epidemic proportions, yet these patients are still ignored by investigators and initiators of clinical trials in all medical fields – and are thus excluded from clinical trials. ASN, ERA-EDTA and ISN, collaboratively aim to bring about a paradigm change in medical research and have launched an information campaign to that end.

 [PRESSWIRE] SEATTLE, June 19, 2019 -- Bardy Diagnostics, Inc., ("BardyDx"), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced that MedTech Innovator, the premier nonprofit startup accelerator in the medical technology industry, has selected BardyDx to participate in the organization's 2019 Showcase program, featuring the most promising medical technologies from around the globe.

[PRESSWIRE] Budapest, June 14, 2019 - As chronic kidney disease (CKD) progresses, the kidneys become less able to maintain a healthy balance of acids in the body, a condition known as metabolic acidosis.

[PRESSWIRE] Budapest - June 14, 2019 -- Acute kidney injury (AKI) is a common complication after cardiac surgery. The severity fluctuates from subclinical AKI, an increase in biochemical markers of kidney injury, to severe AKI requiring renal replacement therapy with dialysis.